Serum insulin and leptin levels and valproate-associated obesity.
Verrotti
Alberto
A
di Corcia
Giovanna
G
Salladini
Carmela
C
Trotta
Daniela
D
Morgese
Guido
G
Chiarelli
Francesco
F
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001823:Body Composition / Q000502:physiology; D015992:Body Mass Index; D002648:Child; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D005246:Feedback / Q000502:physiology; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D020738:Leptin / Q000097:blood*; D008297:Male; D009765:Obesity / Q000097:blood / Q000139:chemically induced*; D012307:Risk Factors; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D007328:Insulin; D020738:Leptin; D014635:Valproic Acid